...
首页> 外文期刊>Current medical research and opinion >Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.
【24h】

Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.

机译:DETP施用后急性软组织损伤的DETP应用术后显着疼痛减少的时间。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Nonsteroidal anti-inflammatory drugs (NSAIDs) provide fast and effective acute pain relief, but systemic administration has increased risk for some adverse reactions. The diclofenac epolamine 1.3% topical patch (DETP) is a topical NSAID with demonstrated safety and efficacy in treatment of acute pain from minor soft tissue injuries. Significant pain reduction has been observed in clinical trials within several hours following DETP application, suggesting rapid pain relief; however, this has not been extensively studied for topical NSAIDs in general. This retrospective post-hoc analysis examined time to onset of significant pain reduction after DETP application compared to a placebo patch for patients with mild-to-moderate acute ankle sprain, evaluating the primary efficacy endpoint from two nearly identical studies. RESEARCH DESIGN AND METHODS: Data from two double-blind, randomized, parallel-group, placebo-controlled studies (N = 274) of safety and efficacy of the DETP applied once daily for 7 days for acute ankle sprain were evaluated post-hoc using statistical modeling to estimate time to onset of significant pain reduction following DETP application. MAIN OUTCOME MEASURES: Pain on active movement on a 100 mm Visual Analog Scale (VAS) recorded in patient diaries; physician- and patient-assessed tolerability; and adverse events. RESULTS: DETP treatment resulted in significant pain reduction within approximately 3 hours compared to placebo. Within-treatment post-hoc analysis based on a statistical model suggested significant pain reduction occurred as early as 1.27 hours for the DETP group. The study may have been limited by the retrospective nature of the analyses. In both studies, the DETP was well tolerated with few adverse events, limited primarily to application site skin reactions. CONCLUSION: The DETP is an effective treatment for acute minor soft tissue injury, providing pain relief as rapidly as 1.27 hours post-treatment. Statistical modeling may be useful in estimating time to onset of pain relief for comparison of topical and oral NSAIDs.
机译:目的:非甾体抗炎药(NSAIDs)提供快速有效的急性疼痛缓解,但系统施用的风险增加了一些不良反应。双氯芬酸欧宝甲胺1.3%局部贴剂(DETP)是一种局部NSAID,具有证明的安全性和疗效治疗急性组织损伤的急性疼痛。在DETP应用后几个小时内在临床试验中观察到显着的疼痛减少,表明快速疼痛缓解;然而,这尚未广泛研究局部NSAIDs。该回顾性后HOC分析检查了与患有轻度至中度急性踝扭伤的患者的安慰剂贴剂相比,在DEDP应用后开始发生显着疼痛降低的时间,从两个几乎相同的研究评估初级疗效终点。研究设计和方法:每天一次每天施用一次双盲,随机,并行组,DECP的安全性和疗效的数据的数据,用于急性踝扭伤的7天,进行急性踝扭伤7天统计学建模以估算DETP应用术后显着疼痛减少的时间。主要结果措施:在患者日记中记录的100 mm视觉模拟量表(VAS)上的主动运动疼痛;医生和患者评估的耐受性;和不良事件。结果:与安慰剂相比,DETP治疗导致大约3小时内产生显着的疼痛。基于统计模型的治疗后HOC分析表明,对于DETP组,早期发生了显着的疼痛减少。该研究可能受到分析的回顾性的限制。在这两项研究中,DETP具有很少有不良事件的耐受性,主要是应用部位皮肤反应的限制。结论:DETP是对急性轻微软组织损伤的有效治疗方法,可在治疗后1.27小时迅速提供疼痛缓解。统计建模可用于估计静止疼痛缓解的时间,以便进行局部和口腔NSAID的比较。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号